Bruce & Co’s Amryt Pharma AMYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-315,182
Closed -$2.3M – 38
2022
Q4
$2.3M Hold
315,182
– – 0.59% 25
2022
Q3
$2.18M Hold
315,182
– – 0.6% 25
2022
Q2
$2.2M Hold
315,182
– – 0.52% 25
2022
Q1
$2.6M Hold
315,182
– – 0.53% 23
2021
Q4
$3.4M Sell
315,182
-92,258
-23% -$996K 0.68% 21
2021
Q3
$4.92M Buy
+407,440
New +$4.6M 1.05% 19

Other funds holding AMYT

Bruce & Co's AMYT Position: Q1 2023 in Review

Bruce & Co sold out of Amryt Pharma (AMYT) in Q1 2023, closing a stake of 315,182 shares — an estimated $2.3M sold.

Bruce & Co first reported a position in AMYT in Q3 2021 and held it in 6 quarters. The position peaked at $4.92M in Q3 2021. 79 funds tracked by Wall St. Rank hold AMYT as of Q1 2023.

  • Bruce & Co reported no remaining Amryt Pharma position as of Q1 2023 after selling out during the quarter.
  • Bruce & Co sold 315,182 Amryt Pharma shares in Q1 2023, an estimated $2.3M.
  • Bruce & Co first reported a position in Amryt Pharma in Q3 2021 and held it in 6 quarters.
  • Bruce & Co's Amryt Pharma position peaked at $4.92M in Q3 2021.
  • 79 funds tracked by Wall St. Rank held Amryt Pharma as of Q1 2023.

Based on Bruce & Co's 13F filing for Q1 2023, filed 12 May 2023.